Stocks and Investing Stocks and Investing
Wed, September 23, 2020
Tue, September 22, 2020
Mon, September 21, 2020
Sun, September 20, 2020
Fri, September 18, 2020
Thu, September 17, 2020
Wed, September 16, 2020
Tue, September 15, 2020
Mon, September 14, 2020

Paul Choi Upgraded (VIR) to Strong Buy and Increased Target to $54 on, Sep 14th, 2020


Published on 2024-10-27 13:16:32 - WOPRAI
  Print publication without navigation


Paul Choi of Goldman Sachs, Upgraded "Vir Biotechnology, Inc." (VIR) to Strong Buy and Increased Target from $48 to $54 on, Sep 14th, 2020.

Paul has made no other calls on VIR in the last 4 months.



There are 2 other peers that have a rating on VIR. Out of the 2 peers that are also analyzing VIR, 1 agrees with Paul's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Anupam Rama of "JP Morgan" Upgraded from Sell to Hold and Decreased Target to $29 on, Friday, September 11th, 2020


This is the rating of the analyst that currently disagrees with Paul


  • Alan Carr of "Needham" Initiated at Strong Buy and Held Target at $62 on, Thursday, August 20th, 2020